Clinical trials
Completed Phase 2 Iron Overload trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 11 |
| Hangzhou Zede Pharma-Tech Co., Ltd. | 2 |
| Andrea Kew | 1 |
| ApoPharma | 1 |
| Case Western Reserve University | 1 |
| Elliott Vichinsky | 1 |
| Lipomed | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Novartis | 1 |
| Rennes University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Iron Overload | 23 |
| Thalassemia | 9 |
| beta-Thalassemia | 6 |
| Myelodysplastic Syndromes | 4 |
| Anemia | 3 |
| Anemia, Sickle Cell | 3 |
| Hemochromatosis | 3 |
| Anemia, Diamond-Blackfan | 2 |
| Hematologic Diseases | 2 |
| Hemoglobinopathies | 2 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.